![]() Salarius Pharmaceuticals Salarius Pharmaceuticals is a clinical-stage biotechnology company developing epigenetic-based cancer treatments. | ![]() AsclepiX Therapeutics AsclepiX Therapeutics is a biopharmaceutical company which focuses on therapies based on a peptide platform. | |||
Founding Date | Founding Date 2012 | Founding Date 2011 | Founding Date 2018 | Founding Date 2011 |
Type | Type Public | Type Public | Type Public | Type Private |
Tags | ||||
Locations | Locations HQ | Locations Houston, US HQ | Locations South San Francisco, US HQ Bothell, US Seattle, US | Locations Baltimore, US HQ Jersey City, US |
Employees | Employees 7 | Employees 1225% decrease | Employees 188 | Employees 7 |
Valuation ($) | Valuation ($) 122.2 m | Valuation ($) 2.4 m | Valuation ($) 243.3 m | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $61k (FY, 2024) | Revenue (est.) N/A |
Net income | Net income ($25.5m) (FY, 2024) | Net income ($5.6m) (FY, 2024) | Net income ($343m) (FY, 2024) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised $ 7.5m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 40m |
Salarius Pharmaceuticals is a clinical-stage biotechnology company developing epigenetic-based cancer treatments.
View companyLyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.
View companyAsclepiX Therapeutics is a biopharmaceutical company which focuses on therapies based on a peptide platform.
View company